Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.34% Nasdaq Up0.16%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

8.05 May 21, 4:00PM EDT

Add to Portfolio
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Assets
Current Assets
Cash And Cash Equivalents14,677  35,252  28,412  
Short Term Investments -  4,211  100  
Net Receivables -  7   -  
Inventory -   -   -  
Other Current Assets430  534  200  
Total Current Assets 15,107   40,004   28,712  
Long Term Investments -   -   -  
Property Plant and Equipment56  67  57  
Goodwill3,208  3,208  3,208  
Intangible Assets -   -   -  
Accumulated Amortization -   -   -  
Other Assets198  209  137  
Deferred Long Term Asset Charges -   -   -  
Total Assets 18,569   43,488   32,114  
Liabilities
Current Liabilities
Accounts Payable8,039  9,767  5,947  
Short/Current Long Term Debt -   -   -  
Other Current Liabilities -   -  245  
Total Current Liabilities 8,039   9,767   6,192  
Long Term Debt -   -   -  
Other Liabilities36  2,674  2,674  
Deferred Long Term Liability Charges -   -   -  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 8,075   12,441   8,866  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock72  71  62  
Retained Earnings(392,608)(369,887)(341,764)
Treasury Stock(357)(357)(357)
Capital Surplus403,387  401,220  365,307  
Other Stockholder Equity -   -   -  
Total Stockholder Equity 10,494   31,047   23,248  
Net Tangible Assets 7,286   27,839   20,040  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.